IRIS Accounts Production v25.4.0.155 07418051 director 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074180512024-03-31074180512025-03-31074180512024-04-012025-03-31074180512023-03-31074180512023-04-012024-03-31074180512024-03-3107418051ns15:EnglandWales2024-04-012025-03-3107418051ns14:PoundSterling2024-04-012025-03-3107418051ns10:Director12024-04-012025-03-3107418051ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107418051ns10:SmallEntities2024-04-012025-03-3107418051ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107418051ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107418051ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107418051ns10:FullAccounts2024-04-012025-03-3107418051ns10:RegisteredOffice2024-04-012025-03-3107418051ns5:CurrentFinancialInstruments2025-03-3107418051ns5:CurrentFinancialInstruments2024-03-3107418051ns5:Non-currentFinancialInstruments2025-03-3107418051ns5:Non-currentFinancialInstruments2024-03-3107418051ns5:ShareCapital2025-03-3107418051ns5:ShareCapital2024-03-3107418051ns5:RetainedEarningsAccumulatedLosses2025-03-3107418051ns5:RetainedEarningsAccumulatedLosses2024-03-3107418051ns5:FurnitureFittings2024-04-012025-03-3107418051ns5:FurnitureFittings2024-03-3107418051ns5:FurnitureFittings2025-03-3107418051ns5:FurnitureFittings2024-03-3107418051ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-03-3107418051ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-03-31
REGISTERED NUMBER: 07418051 (England and Wales)















AMBIANCE & SOLACE THERAPIES LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025






AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company information 1

Balance sheet 2

Notes to the financial statements 4


AMBIANCE & SOLACE THERAPIES LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Ms B F Ronewicz





REGISTERED OFFICE: 24 Willian Road
Hitchin
Hertfordshire
SG4 0LS





REGISTERED NUMBER: 07418051 (England and Wales)





ACCOUNTANTS: Venthams Limited
Chartered Accountants
Millhouse
32-38 East Street
Rochford
Essex
SS4 1DB

AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 44 58

CURRENT ASSETS
Stocks 35 35
Cash at bank 565 189
600 224
CREDITORS
Amounts falling due within one year 5 69,240 62,878
NET CURRENT LIABILITIES (68,640 ) (62,654 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(68,596

)

(62,596

)

CREDITORS
Amounts falling due after more than
one year

6

69

467
NET LIABILITIES (68,665 ) (63,063 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (68,666 ) (63,064 )
(68,665 ) (63,063 )

AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 24 November 2025 and were signed by:





Ms B F Ronewicz - Director


AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Ambiance & Solace Therapies Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services
Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
- the amount of revenue can be measured reliably;
- it is probable that the company will receive the consideration due under the contract;
- the stage of completion of the contract at the end of the reporting period can be measured reliably; and
- the costs incurred and the costs to complete the contract can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


2. ACCOUNTING POLICIES - continued

Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Financial instruments
The company has elected to apply the provisions of Section 11 "Basic Financial Instruments" of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Balance Sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments

Going concern
The financial statements have been prepared on a going concern basis, despite the net current liabilities, due to the continuing support of the director.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

AMBIANCE & SOLACE THERAPIES LTD (REGISTERED NUMBER: 07418051)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 April 2024
and 31 March 2025 695
DEPRECIATION
At 1 April 2024 637
Charge for year 14
At 31 March 2025 651
NET BOOK VALUE
At 31 March 2025 44
At 31 March 2024 58

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 400 400
Trade creditors 380 250
Directors' current accounts 67,644 61,448
Accruals and deferred income 816 780
69,240 62,878

6. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2025 2024
£    £   
Bank loans - 1-2 years 69 467